|
|
||||||||
Laboratory for Research in Neonatal Physiology, Department of Physiology, University of Tennessee, Memphis, Tennessee 38163
| |
ABSTRACT |
|---|
|
|
|---|
Endothelium-derived prostanoids are predominant vasorelaxant factors in the cerebral circulation of newborn pigs in vivo, whereas in older pigs nitric oxide (NO)-mediated responses also contribute to the regulation of cerebral vascular tone. We compared the expression and activities of NO synthase and cyclooxygenase in the cerebral microcirculation of newborn and adult pigs. In adult animals, expression and activity of endothelial NO synthase in cerebral microvessels and in cultured cerebral endothelial cells is two- to threefold higher than in newborn pigs; acetylcholine and bradykinin cause a greater increase in NO production in adult pigs. Expression and activity of cyclooxygenase in cerebral microvascular endothelial cells is similar in newborn and adult pigs; acetylcholine and bradykinin stimulated dilator prostanoid production to the same degree in both age groups. Endothelial prostanoid synthesis in cerebral microvessels and cultured endothelial cells was inhibited 30-70% by NS-398, reflecting a large contribution of COX-2 in both newborn and adult animals. These data indicate that in the cerebral circulation of pigs, NO synthase is age-dependently upregulated, whereas endothelial cyclooxygenase is not altered during postnatal development.
prostaglandins; nitric oxide; cyclooxygenase; nitric oxide synthase
| |
INTRODUCTION |
|---|
|
|
|---|
IN THE CEREBRAL CIRCULATION of newborn pigs, dilator prostanoids, but not nitric oxide (NO), are predominant vasorelaxant factors that contribute to the vasodilation of pial arterioles in response to hypercapnia, acetylcholine, and histamine (1, 15, 22). In older pigs, NO-mediated responses also contribute to the regulation of cerebral vascular tone (1, 31, 32). The implication of these physiological findings is that the production of endothelium-derived vasorelaxant factors, prostanoids, and NO is developmentally regulated during the postnatal period. NO synthase and cyclooxygenase are the key enzymes in synthesis of the vasorelaxant factors. Endothelial Ca2+-dependent NO synthase could be regulated not only at transcriptional and translational levels but also posttranslationally by protein phosphorylation (2, 17, 18).
Cyclooxygenase is represented by two isoforms encoded by different genes, COX-1 and COX-2. COX-1 is a constitutive "housekeeping" enzyme in a variety of prostanoid-producing cells, whereas COX-2 as an early response gene product is largely induced by mitogens (8, 28). However, in the cerebral circulation of newborn pigs, COX-2 protein is constitutively expressed in microvessels (20, 23), in vascular endothelium in the choroid plexus (29), and in cultured microvascular cells (19, 20). In addition, COX-2 provides a major functional contribution to dilator prostanoid synthesis (19, 23). In cerebral vascular cells from newborn pigs, constitutively expressed COX-2 can be posttranslationally activated by tyrosine phosphorylation (19).
Multiple pathways for the regulation of NO synthase and cyclooxygenase at transcriptional, translational, and posttranslational levels can account for developmental changes in the expression and activity of both enzymes. In the present paper, we tested the hypothesis that in the cerebral circulation of pigs endothelial NO synthase (eNOS) activity is increased, whereas cyclooxygenase activity is inhibited, during the postnatal development. To test this hypothesis, we compared the expression and activities of eNOS and cyclooxygenase in isolated microvessels and in cultured endothelial cells from the cerebral cortex of newborn and adult pigs. The results of the present study demonstrated that our initial hypothesis should be modified. The expression of eNOS is upregulated in adult pigs and accounts for the increased production of endothelial NO in the cerebral microcirculation. However, the expression of endothelial cyclooxygenase, the functional role of COX-1 and COX-2 isoforms, and the production of endothelium-derived dilator prostanoids in cerebral circulation in pigs appear to remain unaltered on maturation.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Protocols involving animals were approved by the Animal Care and Use Committee at the University of Tennessee, Memphis. All procedures were done using aseptic techniques.
Materials. Cell culture reagents were obtained from Life Technologies (Gaithersburg, MD) and Sigma (St. Louis, MO). Matrigel (growth factor reduced) was purchased from Becton Dickinson (Bedford, MA). NG-monomethyl-L-arginine (L-NMMA) was from Sigma. L-[U-14C]arginine was from DuPont (Wilmington, DE); NS-398 and arachidonic acid (peroxide-free) were from Cayman (Ann Arbor, MI). Iloprost was a gift from Schering, Germany.
Isolation of cerebral microvessels. Newborn piglets (3-5 days) were anesthetized with ketamine-acepromazine (33 and 3.3 mg/kg), the brain was removed, and the cortex was dissected. Brains from adult pigs were freshly collected at a local abattoir. Brain cortex was gently homogenized using a Dounce homogenizer with a loose-fitting pestle in culture medium 199 containing 100 U/ml penicillin, 100 µg/ml streptomycin, and 2.5 µg/ml amphotericin B. Cerebral microvessels (60-300 µm) were isolated by consequent filtration of the brain homogenate through 300- and 60-µm nylon mesh screens.
Cultured cells. Primary cultures of cerebral microvascular cells were established as previously described (19). For smooth muscle cell explants, cerebral microvessels were plated directly onto 12-well Costar plates coated with Matrigel. Endothelial cells were isolated by collagenase-dispase treatment (1 mg/ml for 2 h at 37°C) followed by Percoll density gradient centrifugation and plated onto Matrigel-coated Costar plates. Cells were cultured in Dulbecco's modified Eagle's medium with 20% fetal bovine serum, 30 µg/ml endothelial cell growth supplement, 1 U/ml heparin, and antibiotic-antimycotic mixture in a 5% CO2 air incubator at 37°C until confluence (5-7 days for endothelial cells and 13-15 days for smooth muscle cells).
All experiments were performed on confluent quiescent cells. To achieve confluence, cells were exposed to a serum-depleted medium (0% fetal bovine serum, 0% endothelial cell growth supplement) for 15-20 h before the experiment.
Prostanoid production. Cells were rinsed with Dulbecco-modified
phosphate-buffered saline (PBS) and incubated in 1 ml of
artificial cerebrospinal fluid (aCSF), an incubation medium similar to
cortical cerebrospinal fluid (in mM, 3.0 KCl, 1.5 MgCl2,
1.5 CaCl2, 132 NaCl, 6.6 urea, 3.7 dextrose, and 24.6 NaHCO3 equilibrated with 5% CO2 and air to pH
7.4-7.5; PCO2, 32-36 mmHg;
PO2, 100-120 mmHg). When indicated,
ionomycin (10
6 M), acetylcholine
(10
5 M), or bradykinin
(10
5 M) was added to the incubation
medium. To determine the contribution of COX-2 to prostanoid
synthesis, cells were pretreated for 20 min before the experiment
with NS-398 (10
5 M). As we have
demonstrated before, 10
5 to
10
4 M NS-398 effectively inhibited
cyclooxygenase activity in COX-2 expressing cells (endothelial and
smooth muscle cells from cerebral microvessels of newborn pigs) (19,
20) but not in COX-1 expressing cells [subcultured human
umbilical vein endothelial cells (HUVECs) and Swiss 3T3
fibroblasts] (19). After 30 min of incubation at
37°C, the medium was aspirated and stored at
20°C for
prostanoid determination. For protein determination, cells were
extracted with 0.1 N HCl; protein was detected using the Pierce
micro-BCA assay (Pierce Chemical, Rockford, IL).
Cyclooxygenase activity. Cyclooxygenase activity was detected
as prostanoid production from arachidonic acid (19). Freshly isolated
cerebral microvessels or cultured endothelial cells were washed twice
with PBS and incubated with 10-30 µM arachidonic acid in 1 ml of
aCSF for 10-20 min at 37°C. The incubation medium was
aspirated and stored at
20°C for prostanoid determination. To determine the functional contribution of COX-2, microvessels and
cells were pretreated for 20 min with the COX-2 selective inhibitor
NS-398 (10
5 M).
Prostanoid assays. Concentrations of 6-keto-PGF1
(the stable hydrolysis product of prostacyclin) and PGE2 in
the cell incubation medium were determined by radioimmunoassay.
Nitrite-nitrate assays. Endothelial cells were incubated in
Krebs-Ringer buffer for 1 h at 37°C without and with
10
5 M bradykinin or acetylcholine. To
control the specificity of NO synthase-derived nitrite-nitrate
detection, we added the NO synthase inhibitor L-NMMA (1 mM)
or EDTA (5 mM) to the incubation medium; heat-inactivated cell
homogenate (100°C, 5 min) was used as an additional control. The
amount of the final products of NO metabolism in the incubation medium
was detected by a nitrate-nitrite assay kit (Cayman Chemical). Cell
medium (80 µl) pretreated with nitrate reductase to convert nitrate
to nitrite was mixed with Griess reagents (0.5% sulfanilamide and
0.05% naphthylethylenediamine dihydrochloride in 5% phosphoric acid);
the absorbance at 540 nm was measured.
NO synthase activity. NO synthase activity was detected in
intact endothelial cells and in cell homogenates by the conversion of
L-[14C]arginine to
L-[14C]citrulline (25). To
determine total NO synthase activity, cells were incubated with
L-[14C]arginine (0.5 µCi/ml) for
30 min at 37°C. When indicated, 10
5
M bradykinin or 10
5 M acetylcholine was
added to the incubation medium. L-NMMA (1 mM) and 5 mM EDTA
were used for the specificity of Ca2+-dependent NO synthase
detection. At the end of the incubation, the cells were disrupted by
sonication in a cold 50 mM HEPES buffer (pH 7.5) containing 5 mM EDTA
and clarified by centrifugation (5,000 g, 10 min). Excess
[14C]arginine was removed by binding to
Dowex-50W-X8 cation exchange resin (Na+ form) in 50 mM
HEPES (pH 7.5). The amount of [14C]citrulline
in supernatant was detected by liquid scintillation.
To determine NO synthase activity in cell homogenates, endothelial cells were disrupted by sonication in cold 50 mM HEPES buffer (pH 7.5) containing protease inhibitors (1 mM EDTA, 1 mM dithiothreitol, 80 mg/l leupeptin, 40 mg/l aprotinin, 40 mg/l phenylmethylsulfonyl fluoride, and 35 mg/l sodium orthovanadate). Cell homogenates were incubated for 15-60 min at 37°C in a reaction mixture (100 µl total volume, 30-50 µg protein) containing 50 mM HEPES (pH 7.5), 2 mM CaCl2, 1 mM NADPH, 10 µM FAD, 100 µM tetrahydrobiopterin, 10 µM L-arginine, and L-[14C]arginine (105 count/min per tube) (25, 27). Unreacted [14C]arginine was removed by binding to 0.5 ml of Dowex-50W-X8 cation exchange resin (Na+ form) in 50 mM HEPES (pH 7.5; ratio 1:1, wt/vol). The Dowex pellet was washed twice by centrifugation using 0.5 ml of cold 50 mM HEPES, pH 7.5. Supernatants were combined, and the amount of [14C]citrulline was detected by liquid scintillation counting. To control the specificity of NO synthase activity detection, we added L-NMMA (1 mM) or EDTA (5 mM) to the incubation medium; heat-inactivated cell homogenate (100°C, 5 min) was used as an additional control. To calculate NO synthase activity, we subtracted nonspecific background (detected as [14C]citrulline formation resistant to 1 mM L-NMMA) from the total amount of [14C]citrulline.
cAMP and cGMP formation by vascular smooth muscle cells. Smooth
muscle cells were washed twice with PBS and incubated in aCSF with the
stable prostacyclin analog iloprost
(10
10-10
6
M) or the NO donor sodium nitroprusside
(10
10-10
6
M) at 37°C for 15 min. Cyclic nucleotides were extracted from the
cells by sonication in 0.1 N HCl (21). Cell homogenates were clarified
by centrifugation, neutralized by 1 N NaOH, and stored at
60°C. Aliquots were used for protein determination by the
Pierce micro-BCA method (Pierce Chemical). cAMP and cGMP in cell
extracts were determined by radioimmunoassay (21). Acetylation of
samples was performed immediately prior to assay to increase the
sensitivity of the method as described (21). Cyclic nucleotide content
was normalized to cell protein.
Western blotting. Cells were solubilized with Laemmli sample buffer (10 min, 100°C), and extracts were clarified by centrifugation. Samples (20-50 µg protein/lane) were separated by 7.5% polyacrylamide SDS gel electrophoresis as described (20). Biotinylated molecular weight protein standards (Bio-Rad) and prestained protein standards (Sigma) were used. For the specific standards, we used COX-2 from sheep placenta (Cayman Chemical), COX-1 from ram seminal vesicles (Oxford Biomed Research, Oxford, MI), and eNOS (Transduction Laboratories; Lexington, KY). The separated proteins were electrotransferred to polyvinylidene difluoride-membranes (Micron Separations). Membranes were probed with 1) COX-2 (human) polyclonal antiserum (Cayman, at 1:10,000 dilution) (20); 2) COX-1 peptide polyclonal antiserum (PG-16 from Oxford Biomed, at 1:1,000 dilution) (20); and 3) eNOS monoclonal antibodies (Transduction Laboratories, at 1:2,000 dilution). As secondary antibody, we used peroxidase-conjugated donkey anti-rabbit or anti-mouse IgG (dilution 1:10,000; Jackson Immunoresearch Laboratories, West Grove, PA). Streptavidin-biotin-horseradish peroxidase complex (Amersham, at 1:1,000 dilution) was added to the second antibody incubation medium to develop biotinylated standards. Blots were developed using a chemiluminescence detection system (DuPont).
Statistical analysis. Data are presented as means ± SE of absolute values or percentage of control. Data were analyzed by ANOVA for repeated measurements, followed by Fisher's test for protected least-significant difference to isolate differences among groups. P < 0.05 was considered significant in all statistical tests.
| |
RESULTS |
|---|
|
|
|---|
NO synthase and cyclooxygenase expression in cerebral microvessels
and in cultured cerebral microvascular endothelial cells. eNOS is
expressed in freshly isolated cerebral microvessels and in cultured
cerebral microvascular endothelial cells from newborn and adult pigs.
The expression of eNOS in microvessels and cultured cells from adult
pigs is two- to threefold higher than in newborn pigs (Fig.
1). As we have found previously, COX-1 and
COX-2 isoforms are constitutively expressed in cerebral
microcirculation of newborn pigs (20). We compared COX-1 and COX-2
protein expression in freshly isolated cerebral microvessels and in
cultured microvascular endothelial cells from newborn and adult
animals. No differences were found in COX-2 (Fig. 1) and COX-1 (data
not shown) expression between the age groups.
|
NO synthase activity in cerebral microvascular endothelial cells.
Cerebral microvascular endothelial cells from newborn and adult
pigs demonstrate Ca2+-dependent NO synthase activity as
measured by [14C]citrulline formation from
[14C]arginine by intact cells and cell
homogenates. L-NMMA (1 mM) inhibited 60-70% of the
total NO synthase activity in intact cells and in cell homogenates from
both newborn and adult pigs (data not shown). In intact endothelial
cells from adult pigs, basal and stimulated NO synthase activity was
two- to threefold higher than in cells from newborns (Fig.
2). Endothelial cells from both newborn and
adult pigs responded to acetylcholine
(10
5 M) and bradykinin
(10
5 M) by increasing NO synthase
activity 1.3- to 1.5-fold above the basal level (Fig. 2). Increased NO
synthase activity in adult pigs was confirmed using endothelial cell
homogenates: total NO synthase activity was 20 ± 5 × 103 and 120 ± 30 × 103 counts/min
[14C]citrulline/mg protein in newborns and
adults, respectively (P < 0.005);
L-NMMA-inhibited activity was 8 ± 2 × 103 and 25 ± 5 × 103 counts/min
[14C]citrulline/mg protein in newborns and
adults, respectively (P < 0.005). Nitrate-nitrite production
by endothelial cells from adult pigs was elevated under basal
conditions and in the presence of 10
5 M
bradykinin (data not shown); however, the low sensitivity of the assay
did not allow parametric statistical analysis.
|
Cyclooxygenase activity and prostanoid production in cerebral
microvessels and in cultured microvascular endothelial cells. Cyclooxygenase activity (as prostanoid production from exogenous arachidonic acid) in freshly isolated cerebral microvessels and in
cultured endothelial cells from adult pigs was similar to or even
higher than that of newborn pigs (Figs. 3
and 4). Cultured cerebral microvascular
endothelial cells produce vasodilator prostanoids, prostacyclin (as
6-keto-PGF1
), and PGE2 under basal
conditions and on stimulation (Fig. 4, A and B). We
found no differences in the ability of cells from newborn and adult
pigs to produce prostanoids from endogenous substrate under basal
conditions or when ionomycin was added to stimulate phospholipase
A2 (PLA2) (Fig. 4, A and B). We
also found no age-related differences in receptor-mediated responses of
endothelial cells; acetylcholine (10
5 M)
and bradykinin (10
5 M) stimulated
PGE2 production two- to threefold above the basal level in
newborn and adult pigs (Fig. 5).
|
|
|
We investigated the functional contribution of COX-1 and COX-2 to
prostanoid synthesis in cerebral microcirculation of newborn and adult
pigs. As we have reported before, NS-398
(10
5-10
4
M) effectively inhibited cyclooxygenase activity in COX-2 expressing cells (in this case, newborn pig vascular endothelial and smooth muscle
cells in primary culture) (19, 20) with no effect in COX-1 expressing
cells (subcultured HUVECs and Swiss 3T3 fibroblasts) (19). These data
indicate that NS-398 can be used to probe for functional contributions
of COX-2 to prostanoid production. NS-398 inhibited total
cyclooxygenase activity in cerebral microvessels (30-50%; Fig. 3,
A and B) and in endothelial cells from newborn and
adult pigs (50-70%; Fig. 6B),
indicating functional recruitment of COX-2 in both age groups. COX-1
(as reflected by NS-398-resistant prostanoid synthesis) contributed to
30-70% of the total prostanoid synthesis-COX activity in cerebral
microvessels and in endothelial cells from both newborn and adult pigs
(Figs. 3 and 6).
|
Prostanoid production and cyclooxygenase activity in cerebral
microvascular smooth muscle cells. PGE2 is a major
prostanoid produced by cerebral microvascular smooth cells (22). In
smooth muscle cells from adult pigs, PGE2 production from
endogenous substrate under basal conditions was significantly decreased
compared with that in cells from newborn animals (Fig.
7A). However, in the presence of
ionomycin, the functional difference between the two age groups was
eliminated (Fig. 7A). When exogenous arachidonic acid was
provided to stimulate the cyclooxygenase activity, no differences were
observed between cells from newborn and adult pigs (Fig. 7A).
The dynamics of 6-keto-PGF1
in smooth muscle cells from
newborn and adult pigs revealed a similar pattern under both basal and
stimulated conditions (data not shown). These data indicate that
prostanoid production by cerebral microvascular smooth muscle cells is
decreased in adult animals due to decreased PLA2 activity,
whereas cyclooxygenase activity is similar in both age groups.
|
We investigated the functional contribution of COX-1 and COX-2 to prostanoid production by cerebral smooth muscle cells. We found no difference between NS-398-inhibited prostanoid production from exogenous arachidonic acid (indicator of COX-2 activity) and NS-398-resistant prostanoid production (indicator of COX-1 activity) in newborn and adult pigs (Fig. 7, B and C). Under all experimental conditions, COX-2 accounted for 40-70% of total prostanoid synthesis in smooth muscle cells of newborn and adult pigs.
Responsiveness of cerebral microvascular smooth muscle cells to
vasodilator agents. We compared the ability of cultured cerebral microvascular smooth muscle cells from newborn and adult pigs to
respond to prostacyclin and NO by activation of an appropriate second
messenger system (cAMP and cGMP, respectively). Basal production of
cAMP and cGMP was similar in quiescent confluent smooth muscle cells
from newborns and adults (9.1 ± 2.2 and 13.1 ± 2.8 pmol cAMP/mg
protein, respectively; P > 0.05; 3.2 ± 0.2 and 3.8 ± 0.2 pmol cGMP/mg protein, respectively, P > 0.05; N = 6 independent cultures). We found no age-related differences in
responsiveness of vascular smooth muscle to the prostacyclin receptor
agonist iloprost
(10
10-10
6
M) and to the NO donor sodium nitroprusside
(10
10-10
6
M). Iloprost caused similar dose-dependent increase in smooth muscle
cAMP level in both age groups (3- to 4-fold increase at 10
6 M, P > 0.05, Fig.
8A). Smooth muscle cells from
newborns and adults also demonstrated equal potencies to respond to
sodium nitroprusside by increasing cGMP level (2- to 2.5-fold increase at 10
6 M, P > 0.05, Fig.
8B).
|
| |
DISCUSSION |
|---|
|
|
|---|
In vivo physiological studies in pigs conducted in our laboratory for several years demonstrate that characteristics of endothelial regulation of cerebral blood flow are age dependent (1, 31, 32). In newborn pigs, endothelium-dependent cerebral vascular reactivity to such physiologically important stimuli as hypercapnia and acetylcholine is mediated exclusively by prostanoids but not NO (1, 22, 32), whereas both prostanoids and NO contribute to vascular tone in older pigs (1, 31, 32). In the present study, we compared the expression and activities of NO synthase and cyclooxygenase in isolated cerebral microvessels and in cultured microvascular endothelial cells from newborn and adult pigs. Our results demonstrate that the expression and the activity of eNOS, as well as the receptor-mediated activation of the enzyme by bradykinin and acetylcholine, are increased in adults. No differences between newborn and adult animals were found in the cyclooxygenase isoforms (COX-1 and COX-2) expression or in their activities and functional contribution to the basal or the stimulated endothelial prostanoid synthesis. These data demonstrate that in cerebral microvasculature in pigs, NO production is developmentally upregulated due to the increased expression of eNOS on pig maturation.
NO plays an important role in the regulation of endothelium-dependent responses of cerebral blood flow to hypercapnia and acetylcholine in different adult animal species (6, 24, 26) and in juvenile pigs (1, 31, 32). In juvenile pigs, inhibition of NO production by L-NMMA attenuated the cerebral vasodilation response to hypercapnia (31, 32) and acetylcholine (32), whereas in newborn pigs, L-NMMA did not affect vascular responses to these stimuli (22, 31, 32). These data indicate that endothelial NO-mediated cerebral vascular reactivity in pigs develops postnatally. The absence of NO-mediated responsiveness in the cerebral circulation of newborn pigs could be associated with 1) a low level of basal NO synthesis by the vascular endothelium (decreased expression and/or activity of NO synthase, the key enzyme in NO synthesis or low efficiency of receptor-mediated activation of NO synthase); 2) altered responsiveness of vascular smooth muscle to endothelium-derived NO (decreased activity of NO-activated soluble guanylyl cyclase and/or ineffective coupling between cGMP formation and vascular smooth muscle relaxation). However, we may reject the latter possibility on the basis of our in vivo data that sodium nitroprusside, a NO donor, effectively dilated pial arterioles and increased cortical cGMP in both newborn and juvenile pigs (1). Our present data demonstrate that cerebral microvascular smooth muscle cells from newborn and adult pigs equally respond to a NO donor by activation of cGMP second messenger system. These findings in vivo and in vitro indicate that NO transduction mechanisms are completely developed in the cerebral microvasculature in newborn pigs.
Our present data demonstrate that the production of NO in the cerebral microcirculation is increased in adult pigs compared with newborns. In isolated cerebral microvessels from adult pigs, eNOS-immunoreactive protein and the basal NO synthase activity were two- to threefold higher than in newborn pigs; the differences in NO production between adults and newborns were also retained in primary cultures of microvascular endothelial cells. eNOS is activated by such vasoactive substances as acetylcholine and bradykinin via receptor-mediated mechanisms (3-5, 7, 9, 10, 30). We found that cerebral microvascular endothelial cells from both newborn and adult animals responded to acetylcholine or bradykinin by increasing NO synthase activity 1.3- to 2-fold. Although we have found no differences between the two age groups in relative magnitude of receptor-mediated responses, the values of acetylcholine- and bradykinin-stimulated NO production were significantly higher in adult animals due to the elevated basal NO synthase activity. Quantitative differences between adult and newborn animals were also retained in primary cultures of endothelial cells from cerebral microvessels. Our results suggest that the expression and activity of eNOS are upregulated in the cerebral microcirculation of adult pigs compared with neonatal pigs.
We investigated whether endothelial prostanoid production decreases with age. In vivo data in pigs indicate that the transition from newborn to juvenile age is accompanied by a decreased contribution of dilator prostanoids to endothelium-dependent cerebral vascular responses (1, 31, 32). Prostanoid synthesis is determined by the activities of two rate-limiting enzymes, PLA2, which selectively cleaves arachidonic acid from membrane phospholipids, and cyclooxygenase (prostaglandin G/H synthase), which catalyzes the first committed step in the conversion of arachidonic acid into prostanoids (8, 28). We have found no differences in the ability of endothelial cells from cerebral microvessels of newborn and adult pigs to produce vasodilator prostanoids, prostacyclin, and PGE2 during basal conditions. Ionomycin, which stimulates prostanoid synthesis in a Ca2+-dependent manner by activating PLA2 and increasing endogenous arachidonic acid (16), caused a similar increase in prostanoid synthesis in newborn and adult animals. Acetylcholine and bradykinin, which increase PLA2 activity via receptor-mediated mechanisms (11-14), stimulated prostanoid production by cerebral microvascular endothelial cells to the same degree in newborns and adults. We also found no age-related differences in total cyclooxygenase activity; intact cerebral microvessels and cultured endothelial cells from newborn and adult pigs effectively converted exogenous arachidonic acid to prostacyclin and PGE2. Taken together, our data indicate that in the cerebral circulation in pigs, endothelial prostanoid synthesis, including activities of rate-limiting enzymes, cyclooxygenase, and, apparently, PLA2, as well as receptor-mediated responsiveness to acetylcholine and bradykinin, does not decline on transition from newborn to adult age.
In the cerebral circulation of newborn pigs, COX-2 is a constitutively
expressed cyclooxygenase isoform that provides for a major part of
prostanoid synthesis (19, 23). COX-2 protein is immunodetected in
isolated cerebral microvessels of newborn pigs (23) and in cultured
microvascular endothelial and smooth muscle cells (19, 20). We compared
the expression of COX-2 protein in endothelial cells from newborn and
adult animals; no age-related changes were detected. To detect the
functional contribution of COX-2 to prostanoid synthesis, we used
NS-398, a selective inhibitor of COX-2. NS-398
(10
5-10
4
M) effectively inhibited cyclooxygenase activity in COX-2 expressing newborn pig cerebral microvascular cells in primary culture (19, 20)
with no effect in COX-1 expressing cells (subcultured HUVECs and Swiss
3T3 fibroblasts) (19). In newborn pigs, COX-2 (as NS-398-inhibited
prostanoid synthesis) accounts for 50-80% of total prostanoid
synthesis in isolated cerebral microvessels (23) and in cultured
microvascular endothelial and smooth muscle cells (19, 20). To
investigate whether the functional contribution of endothelial COX-2 to
the biosynthesis of vasodilator prostanoids is regulated age
dependently, we compared the effects of NS-398 in cultured endothelial
cells from newborn and adult animals. We found no age-related
differences in the sensitivity of endothelial prostanoid synthesis to
NS-398. COX-2 (as NS-398-inhibited prostanoid formation) accounted for
50-70% of the total amount of prostanoids produced by the
vascular endothelium in newborn and adult pigs under basal conditions
and on recruitment of PLA2 by ionomycin. Similarly, the
cyclooxygenase activity in endothelial cells (as prostanoid synthesis
from exogenous arachidonic acid) was inhibited 50-70% by NS-398
in both newborn and adult animals. Altogether, these data demonstrate
that in adult pigs, as well as in newborns, COX-2 is a constitutively
expressed cyclooxygenase isoform that provides a major part of the
cerebral vascular endothelial prostanoid synthesis.
It has been reported that in the brain cortex in vivo and in isolated cerebral microvasculature, NS-398 was less effective in inhibiting basal prostanoid synthesis in juveniles vs. newborn animals (23). Because smooth muscle cells have a high capacity for prostanoid biosynthesis (19, 20), we investigated whether a smooth muscle component of the cerebral microvasculature is altered on maturation. In cultured smooth muscle cells from cerebral microvessels of newborn pigs, the basal prostanoid synthesis was five- to sevenfold higher than in adult animals. However, cyclooxygenase activity was identical in smooth muscle cells from newborn and adult animals. Moreover, NS-398 inhibited 60-80% of the cyclooxygenase activity, indicating that COX-2 contributes to the majority of vascular smooth muscle prostanoid synthesis in both newborn and adult animals. The differences in smooth muscle prostanoid production between newborn and adult pigs were completely eliminated when ionomycin was added to stimulate PLA2 and to increase the formation of endogenous arachidonic acid. These data indirectly indicate that PLA2 appears to be the key enzyme that accounts for the decreased prostanoid synthesis in cerebral vascular smooth muscle in adult animals.
Physiological vascular responses may depend not only on production of endothelium-derived vasorelaxant factors but also on the responsiveness of vascular smooth muscle. To address this possibility, we investigated the responsiveness of vascular smooth muscle to prostacyclin and NO by activation of appropriate second messenger system (cAMP and cGMP, respectively). As we conclude from our data, newborn and adult animals have similar prostacyclin receptor-mediated responses as indicated by increased cAMP formation in vascular smooth muscle. We also found no differences between newborn and adult cGMP responses to the NO donor sodium nitroprusside. These data indicate that the two major signal transduction systems (cAMP mediated and GMP mediated) coexist in vascular smooth muscle in newborn and adult animals and have similar sensitivity to the agonists used regardless of age.
Relative contributions of prostanoids and NO to control of cerebral circulation may differ among species (15). In those animals studied, including humans, contributions of each endothelium-derived vasodilator to cerebral blood flow regulation appear to be different in neonates and older individuals. In adult rats, both PG and NO contribute to hypercapnia-induced vasodilation, a major physiologically important cerebral vascular response (24). In juvenile pigs, both NO and prostanoids contribute to vasodilation of cerebral microvessels in response to hypercapnia and acetylcholine, whereas in newborn piglets a role for NO cannot be demonstrated (1, 31, 32). Our data demonstrate that endothelial NO production increases with age due to an increased NO synthase expression and activity in cerebral microvascular endothelial cells. Developmental upregulation of NO production by vascular endothelium may explain the observation that in juvenile pigs NO contributes to cerebral vasodilation responses to hypercapnia and acetylcholine, whereas in newborn pigs prostanoids but not NO contribute to hypercapnia-induced dilation, and acetylcholine causes constriction (1, 31, 32). Dilator prostanoids appear to be important in cerebral circulation of newborn babies. By comparison to newborn piglets, premature human neonates appear to be extremely sensitive to the cyclooxygenase inhibition. COX inhibitors, especially indomethacin, at very low doses are widely used in clinical practice in preterm human babies with patent ductus arteriosus. It has been shown that indomethacin causes a significant reduction in blood flow to the brain and inhibits vasodilation to hypercapnia, suggesting contribution of dilator prostanoids to the cerebral blood flow regulation in human preterms (15). Experimental studies of age-dependent mechanisms regulating cerebral circulation are important in understanding pathophysiological mechanisms underlying such serious medical problems as intracranial hemorrhages, asphyxia complications, and stroke in patients.
In summary, the results of the present study demonstrate developmental changes in the production of endothelium-derived vasorelaxant factors in the cerebral microcirculation of newborn and adult pigs. The expression of eNOS and the production of NO are upregulated in adult animals, whereas the expression of endothelial cyclooxygenase, the functional role of COX-1 and COX-2 isoforms, and the production of endothelium-derived dilator prostanoids remain unaltered on maturation. These changes may account for the increased contribution of NO-mediated influences in the cerebral microcirculation of pigs on maturation; prostanoid-mediated endothelial influences remain important in both newborn and older pigs.
| |
ACKNOWLEDGEMENTS |
|---|
We thank A. Fedinec and L. Balabanova for technical assistance, D. Morse for the illustrations, and J. Emerson-Cobb for editorial assistance.
| |
FOOTNOTES |
|---|
The research was supported in part by the National Heart, Lung, and Blood Institute Grants HL-42851 and HL-34059. H. Parfenova is also supported by a grant-in-aid from Southeast Affiliate of the American Heart Association.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: H. Parfenova, Dept. of Physiology, Univ. of Tennessee, Memphis, 894 Union Ave., Memphis, TN 38163.
Received 30 August 1999; accepted in final form 11 October 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Armstead, W. M.,
S. L. Zuckerman,
M. Shibata,
H. Parfenova,
and
C. W. Leffler.
Different pial arteriolar responses to acetylcholine in newborn and juvenile pig.
J. Cereb. Blood Flow Metab.
14:
1088-1095,
1994[ISI][Medline].
2.
Bredt, D. S.,
and
S. H. Snyder.
Nitric oxide: a physiological messenger molecule.
Annu. Rev. Biochem.
63:
175-195,
1994[ISI][Medline].
3.
Buckley, B. J.,
Z. Mirza,
and
A. R. Whorton.
Regulation of Ca2+-dependent nitric oxide synthase in bovine aortic endothelial cells.
Am. J. Physiol. Cell Physiol.
269:
C757-C765,
1995
4.
Busse, R.,
and
I. Fleming.
Molecular responses of endothelial tissue to kinins.
Diabetes
45, Suppl. 1:
S8-S13,
1996.
5.
Cosentino, F.,
and
T. F. Luscher.
Maintenance of vascular integrity: role of nitric oxide and other bradykinin mediators.
Eur. Heart J.
16, Suppl. K:
4-12,
1995.
6.
Faraci, F. M.,
K. R. Breeze,
and
D. D. Heistadt.
Cerebral vasodilation during hypercapnia: role of glibencamide-sensitive potassium channels and nitric oxide.
Stroke
25:
1679-1683,
1994[Abstract].
7.
Gorlach, C.,
Z. Benyo,
and
M. Wahl.
Dilator effect of bradykinin and acetylcholine in cerebral vessels after brain lesion.
Kidney Int. Suppl.
67:
S226-S227,
1998[Medline].
8.
Griswold, D. E.,
and
J. L. Adams.
Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date.
Med. Res. Rev.
16:
181-206,
1996[ISI][Medline].
9.
Horning, B.,
and
H. Drexler.
Endothelial function and bradykinin in humans.
Drugs
54, Suppl. 5:
42-47,
1997.
10.
Hu, J.,
and
E. E. El-Fakahany.
Role of intercellular and intracellular communication by nitric oxide in coupling of muscarinic receptors to activation of guanylate cyclase in neuronal cells.
J. Neurochem.
61:
578-585,
1993[ISI][Medline].
11.
Kan, H.,
Y. Ruan,
and
K. U. Malik.
Localization and characterization of the subtypes(s) of muscarinic receptor involved in prostacyclin synthesis in rabbit heart.
J. Pharmacol. Exp. Ther.
276:
934-941,
1996
12.
Kan, H.,
Y. Ruan,
and
K. U. Malik.
Signal transduction mechanism(s) involved in prostacyclin production elicited by acetylcholine in coronary endothelial cells of rabbit heart.
J. Pharmacol. Exp. Ther.
282:
113-122,
1997
13.
Kennedy, C. R.,
P. R. Proulx,
and
R. L. Hebert.
Role of PLA2, PLC, and PLD in bradykinin-induced release of arachidonic acid in MDCK cells.
Am. J. Physiol. Cell Physiol.
271:
C1064-C1072,
1996
14.
Lal, M. A.,
P. R. Proulx,
and
R. L. Hebert.
A role for PKC epsilon and MAP kinase in bradykinin-induced arachidonic acid release in rabbit CD cells.
Am. J. Physiol. Renal Physiol.
274:
F728-F735,
1998
15.
Leffler, C. W.,
W. M. Armstead,
and
M. Shibata.
Role of eicosanoids in cerebral hemodynamics.
In: The Regulation of Cerebral Blood Flow, edited by J. W. Phyllis. Boca Raton, FL: CRC, 1993, p. 297-313.
16.
Leslie, C. C.
Properties and regulation of cytosolic phospholipase A2.
J. Biol. Chem.
272:
16709-16712,
1997
17.
Michel, T.,
G. K. Li,
and
L. Busconi.
Phosphorylation and subcellular translocation of endothelial nitric oxide synthase.
Proc. Natl. Acad. Sci. USA
90:
6252-6256,
1993
18.
Natan, C.,
and
Q.-W. Xie.
Nitric oxide synthases: roles, tolls, and controls.
Cell
78:
915-918,
1994[ISI][Medline].
19.
Parfenova, H.,
L. Balabanova,
and
C. W. Leffler.
Posttranslational regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells.
Am. J. Physiol. Cell Physiol.
274:
C72-C81,
1998
20.
Parfenova, H.,
T. H. Eidson,
and
C. W. Leffler.
Upregulation of COX-2 in cerebral microvascular endothelial cells by smooth muscle cell signals.
Am. J. Physiol. Cell Physiol.
273:
C277-C288,
1997
21.
Parfenova, H.,
and
C. W. Leffler.
Effects of hypercapnia on prostanoid and cAMP production by cerebral microvascular cell cultures.
Am. J. Physiol. Cell Physiol.
270:
C1503-C1510,
1996
22.
Parfenova, H.,
M. Shibata,
Z. Zuckerman,
and
C. W. Leffler.
CO2 and cerebral circulation in newborn pigs: cyclic nucleotides and prostanoids in vascular regulation.
Am. J. Physiol. Heart Circ. Physiol.
266:
H1494-H1501,
1994
23.
Peri, K. G.,
P. Hardy,
D. Y. Li,
D. R. Varma,
and
S. Chemtob.
Prostaglandin G/H synthase is a major contributor of brain prostaglandins in the newborn.
J. Biol. Chem.
270:
24615-24620,
1995
24.
Pelligrino, D. A.,
H. M. Koehnig,
and
R. F. Albrecht.
Nitric oxide synthesis and regional blood flow responses to hypercapnia and hypoxia in the rat.
J. Cereb. Blood Flow Metab.
13:
80-87,
1993[ISI][Medline].
25.
Salter, M.,
R. G. Knowles,
and
S. Moncada.
Widespread tissue distribution, species distribution and changes in activity of Ca2+-dependent and Ca2+-independent nitric oxide synthases.
FEBS Lett.
291:
145-149,
1991[ISI][Medline].
26.
Sandor, P.,
K. Komajati,
M. Reivich,
and
I. Nyary.
Major role of nitric oxide in the mediation of regional CO2 responsiveness.
J. Cereb. Blood Flow Metab.
14:
49-58,
1994[ISI][Medline].
27.
Sherman, P. A.,
V. E. Laubach,
B. R. Reep,
and
E. R. Wood.
Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line.
Biochemistry
32:
11600-11605,
1993[Medline].
28.
Smith, W. L.,
and
D. L. DeWitt.
Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs.
Semin. Nephrol.
15:
179-194,
1995[ISI][Medline].
29.
Thrikawala, N.,
F. Bari,
T. C. Beasley,
C. Thore,
and
D. W. Busija.
Effects of ischemia on prostaglandin H synthase-2 expression in piglet choroid plexus.
Prostaglandins and Other Lipid Mediators
56:
77-87,
1998.
30.
Vanhoutte, P. M.,
C. M. Boulanger,
and
J. V. Momboulu.
Endothelium-derived relaxing factors and converting enzyme inhibition.
Am. J. Cardiol.
76:
3E-12E,
1995[Medline].
31.
Willis, A. P.,
and
C. W. Leffler.
NO and prostanoids: age dependence of hypercapnic- and histamine-induced dilations of pig pial arterioles.
Am. J. Physiol. Heart Circ. Physiol.
277:
H299-H307,
1999
32.
Zuckerman, S. L.,
W. M. Armstead,
P. Hsu,
M. Shibata,
and
C. W. Leffler.
Age dependence of cerebrovascular response mechanisms in domestic pigs.
Am. J. Physiol. Heart Circ. Physiol.
271:
H535-H540,
1996
This article has been cited by other articles:
![]() |
J. B. Samora, J. C. Frisbee, and M. A. Boegehold Growth-dependent changes in endothelial factors regulating arteriolar tone Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H207 - H214. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-K. Tong, N. Nicolakakis, A. Kocharyan, and E. Hamel Vascular Remodeling versus Amyloid {beta}-Induced Oxidative Stress in the Cerebrovascular Dysfunctions Associated with Alzheimer's Disease J. Neurosci., November 30, 2005; 25(48): 11165 - 11174. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. White, M. W. Hamade, K. Siami, M. M. Chang, A. Mangalwadi, J. A. Frangos, and W. J. Pearce Maturation enhances fluid shear-induced activation of eNOS in perfused ovine carotid arteries Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2220 - H2227. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Fike, M. R. Kaplowitz, Y. Zhang, and S. L. Pfister Cyclooxygenase-2 and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn pigs J Appl Physiol, March 1, 2005; 98(3): 1111 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Williams, A. D. Hull, and W. J. Pearce Maturational modulation of endothelium-dependent vasodilatation in ovine cerebral arteries Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R149 - R157. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Merkus, B. Houweling, A. Zarbanoui, and D. J. Duncker Interaction between prostanoids and nitric oxide in regulation of systemic, pulmonary, and coronary vascular tone in exercising swine Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1114 - H1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Geary, J. N. Buchholz, and W. J. Pearce Maturation depresses mouse cerebrovascular tone through endothelium-dependent mechanisms Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R734 - R741. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Yakubu and C. W. Leffler L-type voltage-dependent Ca2+ channels in cerebral microvascular endothelial cells and ET-1 biosynthesis Am J Physiol Cell Physiol, December 1, 2002; 283(6): C1687 - C1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Perez-Vizcaino, J. G. Lopez-Lopez, R. Santiago, A. Cogolludo, F. Zaragoza-Arnaez, L. Moreno, M. J. Alonso, M. Salaices, and J. Tamargo Postnatal maturation in nitric oxide-induced pulmonary artery relaxation involving cyclooxygenase-1 activity Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L839 - L848. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lacza, M. Puskar, B. Kis, J. V. Perciaccante, A. W. Miller, and D. W. Busija Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H406 - H411. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang and C. W. Leffler Compensatory role of NO in cerebral circulation of piglets chronically treated with indomethacin Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R400 - R410. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Parfenova, R. A. Neff III, J. S. Alonso, B. V. Shlopov, C. N. Jamal, S. A. Sarkisova, and C. W. Leffler Cerebral vascular endothelial heme oxygenase: expression, localization, and activation by glutamate Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1954 - C1963. [Abstract] [Full Text] [PDF] |
||||